Literature DB >> 18657681

Pharmacology of emerging novel platelet inhibitors.

Dominick J Angiolillo1, Piera Capranzano.   

Abstract

A number of promising antiplatelet therapies currently in advanced clinical testing offer hope for improving cardiovascular outcomes in patients with acute coronary syndromes and those undergoing percutaneous interventions. We review the preclinical pharmacology and selected ongoing clinical trials of promising novel platelet inhibitor therapies.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18657681     DOI： 10.1016/j.ahj.2008.06.004

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


  20 in total

1.  State-of-the-Art: Hypo-responsiveness to oral antiplatelet therapy in patients with type 2 diabetes mellitus.

Authors:  Dharam J Kumbhani; Steven P Marso; Carlos A Alvarez; Darren K McGuire
Journal:  Curr Cardiovasc Risk Rep       Date:  2015-01

2.  Advances in Coronary No-Reflow Phenomenon-a Contemporary Review.

Authors:  Ahmadreza Karimianpour; Anbukarasi Maran
Journal:  Curr Atheroscler Rep       Date:  2018-07-05       Impact factor: 5.113

Review 3.  Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties.

Authors:  Nicola Ferri; Alberto Corsini; Stefano Bellosta
Journal:  Drugs       Date:  2013-10       Impact factor: 9.546

Review 4.  Thienopyridine-associated drug-drug interactions: pharmacologic mechanisms and clinical relevance.

Authors:  Jean-Sébastien Hulot; Jean-Philippe Collet; Gilles Montalescot
Journal:  Curr Cardiol Rep       Date:  2011-10       Impact factor: 2.931

5.  Protease activated receptor-1 (PAR-1) mediated platelet aggregation is dependent on clopidogrel response.

Authors:  Rolf P Kreutz; Jeffrey A Breall; Yvonne Kreutz; Janelle Owens; Deshun Lu; Islam Bolad; Elisabeth von der Lohe; Anjan Sinha; David A Flockhart
Journal:  Thromb Res       Date:  2012-03-28       Impact factor: 3.944

6.  Prasugrel versus clopidogrel in stent-assisted coil embolization of unruptured intracranial aneurysms.

Authors:  Jacques Sedat; Yves Chau; Jean Gaudart; Marina Sachet; Stephanie Beuil; Michel Lonjon
Journal:  Interv Neuroradiol       Date:  2016-10-22       Impact factor: 1.610

Review 7.  Platelet function profiles in patients with diabetes mellitus.

Authors:  Fabiana Rollini; Francesco Franchi; Ana Muñiz-Lozano; Dominick J Angiolillo
Journal:  J Cardiovasc Transl Res       Date:  2013-02-13       Impact factor: 4.132

8.  Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapy.

Authors:  Karthik Balasubramaniam; Girish N Viswanathan; Sally M Marshall; Azfar G Zaman
Journal:  Cardiol Res Pract       Date:  2012-01-05       Impact factor: 1.866

Review 9.  Platelet thrombin receptor antagonism and atherothrombosis.

Authors:  Dominick J Angiolillo; Davide Capodanno; Shinya Goto
Journal:  Eur Heart J       Date:  2009-11-30       Impact factor: 29.983

10.  Spontaneous recanalization of a completely occluded saphenous vein graft two months following acute myocardial infarction with persistent one year patency.

Authors:  Patrick P Hu; Kirk L Peterson; Sotirios Tsimikas
Journal:  J Thromb Thrombolysis       Date:  2009-07       Impact factor: 2.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.